These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11016457)

  • 1. Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy.
    Chibber R; Ben-Mahmud BM; Coppini D; Christ E; Kohner EM
    Diabetes; 2000 Oct; 49(10):1724-30. PubMed ID: 11016457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy.
    Chibber R; Ben-Mahmud BM; Mann GE; Zhang JJ; Kohner EM
    Diabetes; 2003 Jun; 52(6):1519-27. PubMed ID: 12765965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy.
    Ben-Mahmud BM; Mann GE; Datti A; Orlacchio A; Kohner EM; Chibber R
    Diabetes; 2004 Nov; 53(11):2968-76. PubMed ID: 15504978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.
    Ben-Mahmud BM; Chan WH; Abdulahad RM; Datti A; Orlacchio A; Kohner EM; Chibber R
    Diabetologia; 2006 Sep; 49(9):2185-91. PubMed ID: 16832663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
    Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
    Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration.
    Olson JA; Whitelaw CM; McHardy KC; Pearson DW; Forrester JV
    Diabetologia; 1997 Oct; 40(10):1166-71. PubMed ID: 9349597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of advanced glycation end products in retinal microvascular leukostasis.
    Moore TC; Moore JE; Kaji Y; Frizzell N; Usui T; Poulaki V; Campbell IL; Stitt AW; Gardiner TA; Archer DB; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4457-64. PubMed ID: 14507893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes.
    Dupas B; Minvielle W; Bonnin S; Couturier A; Erginay A; Massin P; Gaudric A; Tadayoni R
    JAMA Ophthalmol; 2018 Jul; 136(7):721-728. PubMed ID: 29800967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
    Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.
    Veenstra AA; Tang J; Kern TS
    PLoS One; 2013; 8(10):e78405. PubMed ID: 24205223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats.
    Robison WG; McCaleb ML; Feld LG; Michaelis OE; Laver N; Mercandetti M
    Curr Eye Res; 1991 Apr; 10(4):339-50. PubMed ID: 1829996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.
    Koga K; Yamagishi S; Okamoto T; Inagaki Y; Amano S; Takeuchi M; Makita Z
    Int J Clin Pharmacol Res; 2002; 22(1):13-7. PubMed ID: 12395914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
    Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
    Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control.
    Sander B; Larsen M; Engler C; Lund-Andersen H; Parving HH
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):553-9. PubMed ID: 7887152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.
    Behl Y; Krothapalli P; Desta T; DiPiazza A; Roy S; Graves DT
    Am J Pathol; 2008 May; 172(5):1411-8. PubMed ID: 18403591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytes in diabetic retinopathy.
    Chibber R; Ben-Mahmud BM; Chibber S; Kohner EM
    Curr Diabetes Rev; 2007 Feb; 3(1):3-14. PubMed ID: 18220651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.